Today: 10 June 2026
Lam Research stock (LRCX) jumps on Mizuho target hike — what to watch into Monday and the week ahead

Lam Research stock (LRCX) jumps on Mizuho target hike — what to watch into Monday and the week ahead

New York, January 11, 2026, 14:32 ET — The market is now closed.

Shares of Lam Research (LRCX) surged 8.7% on Friday following Mizuho’s boost of its price target to $220 from $200. The PHLX semiconductor index climbed 2.7%, hitting a new high. “Investors are getting granular and picking the winners and losers,” said Zachary Hill, head of portfolio management at Horizon Investments. Reuters

Lam sees the burst as significant since equipment manufacturers operate upstream in the semiconductor cycle. When chipmakers boost spending, orders can jump sharply; when they hold back, tool stocks tend to react quickly.

Next week, the spotlight turns to major U.S. banks starting their fourth-quarter earnings reports, alongside December’s consumer price index (CPI) release on Tuesday—an inflation gauge closely watched ahead of the Fed’s late-January meeting. “It just seems a little too quiet,” said Michael Arone, chief investment strategist at State Street Investment Management. Reuters

Mizuho maintained its Outperform rating on Lam while raising the price target. The firm continues to see upside in semiconductor capital equipment for 2026 based on valuations, though it anticipates growth will slow after 2025.

Lam wasn’t the only chip-tool stock to surge Friday: Applied Materials climbed 6.9%, KLA jumped 5.6%, and ASML increased 6.7%.

Lam exchanged roughly 16.8 million shares Friday, hitting a peak of $219.42 during the session, while the low settled at $202, according to market data.

Lam supplies tools for depositing and etching layers on silicon wafers, a key part of chip manufacturing. Investors view the stock as a gauge for capital spending at memory producers and logic foundries.

Still, Lam’s steep rally exposes it to risk if chipmakers dial back spending, particularly in memory, where budgets often fluctuate quarterly. Trade policy remains a cloud, too, as companies prepare for a Supreme Court decision on the legality of President Donald Trump’s global tariffs.

Following Friday’s sharp spike, investors will be eyeing if the stock can maintain its momentum when U.S. markets open Monday. Quick rallies often invite profit-taking, especially if interest rates or economic data catch the AI trade off guard.

Lam plans to hold its December-quarter earnings call on Jan. 28 at 2 p.m. Pacific time (5 p.m. ET), right after the U.S. markets close. Investors are keen to hear what management says about customer spending and the flow of new tool orders.

Stock Market Today

  • Apotex Debuts on Toronto Stock Exchange in Largest Life Sciences IPO
    June 10, 2026, 10:06 AM EDT. The Toronto Stock Exchange (TSX) welcomed Apotex Health Corp., marking the largest life sciences initial public offering (IPO) by total proceeds on the exchange, raising $1.3 billion. Apotex, a Canadian global health company, began trading under the symbol APTX on June 11, 2026. The listing reflects the strength of Canadian capital markets and underscores growth in the life sciences sector, which counts 110 companies listed on TSX and TSX Venture Exchange with a combined market capitalization of $26 billion. Apotex provides a wide range of affordable medicines including generics and biosimilars, serving millions worldwide from its Toronto headquarters and global offices. TSX CEO Loui Anastasopoulos praised the listing as showcasing Canadian competitiveness on the global stage.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape
Previous Story

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Uber stock heads into Monday with robotaxi rules back in focus after Waymo protest
Next Story

Uber stock heads into Monday with robotaxi rules back in focus after Waymo protest

Go toTop